Correlation Between Medical Developments and Unibail Rodamco

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medical Developments and Unibail Rodamco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medical Developments and Unibail Rodamco into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medical Developments International and Unibail Rodamco Westfield SE, you can compare the effects of market volatilities on Medical Developments and Unibail Rodamco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medical Developments with a short position of Unibail Rodamco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medical Developments and Unibail Rodamco.

Diversification Opportunities for Medical Developments and Unibail Rodamco

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Medical and Unibail is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Medical Developments Internati and Unibail Rodamco Westfield SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unibail Rodamco West and Medical Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medical Developments International are associated (or correlated) with Unibail Rodamco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unibail Rodamco West has no effect on the direction of Medical Developments i.e., Medical Developments and Unibail Rodamco go up and down completely randomly.

Pair Corralation between Medical Developments and Unibail Rodamco

Assuming the 90 days trading horizon Medical Developments International is expected to under-perform the Unibail Rodamco. In addition to that, Medical Developments is 2.7 times more volatile than Unibail Rodamco Westfield SE. It trades about -0.01 of its total potential returns per unit of risk. Unibail Rodamco Westfield SE is currently generating about 0.09 per unit of volatility. If you would invest  368.00  in Unibail Rodamco Westfield SE on September 1, 2024 and sell it today you would earn a total of  261.00  from holding Unibail Rodamco Westfield SE or generate 70.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medical Developments Internati  vs.  Unibail Rodamco Westfield SE

 Performance 
       Timeline  
Medical Developments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medical Developments International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Unibail Rodamco West 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Unibail Rodamco Westfield SE are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Unibail Rodamco may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Medical Developments and Unibail Rodamco Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medical Developments and Unibail Rodamco

The main advantage of trading using opposite Medical Developments and Unibail Rodamco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medical Developments position performs unexpectedly, Unibail Rodamco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unibail Rodamco will offset losses from the drop in Unibail Rodamco's long position.
The idea behind Medical Developments International and Unibail Rodamco Westfield SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum